GlaxoSmithKline Czech Republic made a net profit of CZK 65.4 mil with revenues of CZK 2,897 mil in 2017, up by 72% and down by 14.6%, respectively, compared to the previous year. This translates into a net margin of 2.26%.
Historically, between 2003 - 2017, the firm’s net profit reached a high of CZK 240 mil in 2011 and a low of CZK -7.67 mil in 2006. Since 2012, the firm's net profit has decreased 60.1% or -16.8% a year on average.
On the operating level, EBITDA reached CZK 97.4 mil, up 56% compared to the previous year. Over the last five years, company's EBITDA has fallen 16.1% a year on average.
You can see all the company’s data at GlaxoSmithKline Czech Republic profile, or you can download a report on the company in the report section.
Helgi Library 
